# US 2008/0306256 A1 · Salts in the Preparation of Cephalosporin Antibiodies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306256 A1
- Document ID: US20080306256A1
- Status: Published application
- Kind: A1
- Application number: 11/631,595
- Filed: 2005-07-04
- Published: 2008-12-11
- Earliest claimed: 2004-07-05
- Assignees: Orchid Chemicals & Pharmaceuticals Limited
- Inventors: Udayampalayam P. Senthilkumar; Venu S. Lakshmipathi; Gnanaprakasam Andrew; Ramasubbu Chandrasekaran; Dindigala Nagender Rao; Gaddam Om Reddy
- Web page: https://patentgrep.com/patent/US20080306256A1

## CPC

- C07D 501/00: Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE cpc-sch-C07D-0993.gif] , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to an improved process for the preparation of cephalosporin antibiotics of formula (I). The present invention also provides new salts of compound of formula (II) and a process for the preparation of these new salts, where n=0.5 to 2. The present invention also provides a process for the preparation of compound of formula (I) using the new salts of formula (II).

## Claims

### Claim 1

A compound of general formula (II)
wherein R1 represents
R4 represents hydrogen or —CHO group, R2 represents hydrogen or methoxy group,
R3 represents hydrogen, —CH2OCOCH3, —CH═CH2, —CH2—O—CO—NH2, —CH—CH—CH3 or a group selected from
Z represents hydrogen, C1-6 alkyl, substituted or unsubstituted aryl; wherein R5 represents hydrogen, trityl, CH3, CRaRbCOORc where Ra and Rb independently represent hydrogen or methyl and Rc represents hydrogen or (C1-C6)alkyl; M represents the dialkyl or dicycloalkyl ethylenediamine group selected form N,N′-diisobutylethylenediamine, N,N′-dicyclohexylethylenediamine, or N,N′-dicyclopentylethylenediamine.

### Claim 2 (depends on 1)

A compound as claimed in claim 1, wherein the compound is
wherein M represents N,N′-diisobutylethylenediamine, N,N′-dicyclohexylethylenediamine, or N,N′-dicyclopentylethylenediamine.

### Claim 3 (depends on 1)

A compound as claimed in claim 1, wherein the compound is
wherein M represents N,N′-diisobutylethylenediamine. N,N′-dicyclohexylethylenediamine, or N,N′-dicyclopentylethylenediamine.

### Claim 4 (depends on 1)

A compound as claimed in claim 1, wherein the compound is
wherein M represents N,N′-diisobutylethylenediamine, N,N′-dicyclohexylethylenediamine, or N,N′-dicyclopentylethylenediamine.

### Claim 5

A process for the preparation of compound of formula (II), which comprising the steps of:
i) condensing the compound of the formula (VI)
with compound of the formula (VII) wherein Y is a group which forms a basis that a compound of formula (VII) is in a reactive form; including halogen, or a group which forms together with the —C═O group to which Y is attached an active ester, and a group which forms together with the —C═O group to which Y is attached a mixed anhydride in the presence of a base and solvent to produce the compound of formula (VIII), and
ii) treating the compound of formula (VIII) with compound of formula (M) to produce the compound of formula (II).

### Claim 6 (depends on 5)

The process according to claim 5, wherein M is selected from N,N′-Diisobutylethylenediamine, N,N′-Dicyclohexylethylenediamine or N,N′-dicyclopentylethylenediamine.

### Claim 7 (depends on 5)

The process according to claim 5, wherein the base used in step (i) is selected from sodium hydroxide, sodium acetate, potassium hydroxide, ammonium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate triethylamine, diethylamine, tributylamine, pyridine, N-methylanilines, N-methylmorpholine and mixtures thereof.

### Claim 8 (depends on 5)

The process according to claim 5, the solvent used in step (i) is selected from ethanol, methanol, isopropanol, THF, cyclohexanol, acetonitrile, DMAc, DMF, N-methylpyrrolidine, ethyl acetate, methylene dichloride, ethylene dichloride, acetone, toluene, tetrahydrofuran, xylene, water or mixtures thereof.

### Claim 9 (depends on 5)

A process according to claim 5, further comprising converting the compound of formula (II) into compound of formula (I) by dissolving the compound of formula (II) in a mixture of organic solvent followed by treating the clear solution with an acid or with sodium exchanging reagent to produce the compound of formula (I).

### Claim 10 (depends on 9)

The process of claim 9, wherein the sodium exchanging reagent is selected from sodium acetate, sodium citrate, sodium lactate, sodium ethylacetoacetate and sodium 2-ethylhexanoate and the solvent used for dissolving sodium exchange reagent is selected from ethanol, methanol, isopropanol, acetonitrile, ethyl acetate, acetone, water or mixtures thereof.

### Claim 11 (depends on 9)

The process of claim 9, wherein the acid is selected from HCl, sulfuric acid, formic acid, acetic acid, perchloric acid, benzenesulfonic acid, p-toluenesulfonic acid, naphthalenesulfonic acid, methanesulfonic acid, trifluoro acetic acid, cationic exchange resin selected from UBK530, UBK 535, UBK 550, UBK 555, PK 220,
PK 228, PK216 resin or mixtures thereof.
